Literature DB >> 14688447

Blood glucose is correlated with cerebrospinal fluid neurotransmitter metabolites.

John C Umhau1, Sarah G Petrulis, Rosalyn Diaz, Robert Rawlings, David T George.   

Abstract

Medications which influence monoaminergic neurotransmission can also have an effect on glucose regulation. In order to better understand the role of central monoaminergic neurotransmission in blood glucose homeostasis, we explored the relation between blood glucose and cerebrospinal fluid metabolite concentrations of monoaminergic neurotransmitters. Under stringently controlled resting conditions, we measured fasting blood glucose and performed lumbar punctures on 41 healthy participants. Peripheral blood glucose concentrations were significantly correlated with the cerebrospinal fluid concentrations of the dopamine metabolite, homovanillic acid and the noradrenaline metabolite, 3-methoxy-4-hydroxyphenylglycol. These correlations may represent a homeostatic relation between brain neurotransmitter activity and blood glucose. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688447     DOI: 10.1159/000074887

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  9 in total

1.  Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Authors:  John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel Hommer; Markus Heilig
Journal:  Arch Gen Psychiatry       Date:  2010-10

Review 2.  Neural vulnerability factors for obesity.

Authors:  Eric Stice; Kyle Burger
Journal:  Clin Psychol Rev       Date:  2018-12-19

3.  Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.

Authors:  Lorenzo Leggio; Lara A Ray; George A Kenna; Robert M Swift
Journal:  Alcohol Clin Exp Res       Date:  2009-05-26       Impact factor: 3.455

Review 4.  Dopamine and glucose, obesity, and reward deficiency syndrome.

Authors:  Kenneth Blum; Panayotis K Thanos; Mark S Gold
Journal:  Front Psychol       Date:  2014-09-17

Review 5.  The Glymphatic System in Diabetes-Induced Dementia.

Authors:  Young-Kook Kim; Kwang Il Nam; Juhyun Song
Journal:  Front Neurol       Date:  2018-10-31       Impact factor: 4.003

Review 6.  Imaging of brain glucose uptake by PET in obesity and cognitive dysfunction: life-course perspective.

Authors:  Patricia Iozzo; Maria Angela Guzzardi
Journal:  Endocr Connect       Date:  2019-11       Impact factor: 3.335

Review 7.  Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction.

Authors:  Francesca Chiara Pignalosa; Antonella Desiderio; Paola Mirra; Cecilia Nigro; Giuseppe Perruolo; Luca Ulianich; Pietro Formisano; Francesco Beguinot; Claudia Miele; Raffaele Napoli; Francesca Fiory
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

8.  Diagnostic Performance of Sex-Specific Modified Metabolite Patterns in Urine for Screening of Prediabetes.

Authors:  Zaifang Li; Yanhui Zhang; Miriam Hoene; Louise Fritsche; Sijia Zheng; Andreas Birkenfeld; Andreas Fritsche; Andreas Peter; Xinyu Liu; Xinjie Zhao; Lina Zhou; Ping Luo; Cora Weigert; Xiaohui Lin; Guowang Xu; Rainer Lehmann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

Review 9.  Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease.

Authors:  Juhyun Song; Jongpil Kim
Journal:  Front Aging Neurosci       Date:  2016-03-30       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.